Watchlist Price Alert

Achieve Life Sciences Inc... (ACHV)

NASDAQ: ACHV · Real-Time Price · USD

3.83

0.31 (8.65%)

At close: Jun 06, 2025, 3:59 PM

3.89

1.76%

After-hours: Jun 06, 2025, 05:12 PM EDT

8.65% (1D)

Bid	3.58
Market Cap	132.67M
Revenue (ttm)	n/a
Net Income (ttm)	-46.16M
EPS (ttm)	-1.35
PE Ratio (ttm)	-2.83
Forward PE	-4.77
Analyst	Buy

Ask	4.03
Volume	220,865
Avg. Volume (20D)	232,958
Open	3.60
Previous Close	3.52
Day's Range	3.60 - 3.85
52-Week Range	1.84 - 5.48
Beta	1.64

About ACHV

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ACHV

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ACHV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 months ago

+15.74%

Achieve Life Sciences shares are trading higher af... Unlock content with Pro Subscription

News

4 days ago · seekingalpha.com

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk

Achieve Life Sciences (ACHV) is positioned for growth with its lead smoking cessation therapy, cytisinicline, advancing through late-stage clinical trials. The company addresses a significant unmet ne...

3 weeks ago · seekingalpha.com

Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript

Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Nicole Jones - Investor Relations Rick Stewart - Chief Executive Officer Cindy ...

2 months ago · seekingalpha.com

Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript

Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ET Company Participants Nicole Jones - IR Richard Stewart - Chief Executive Officer Cindy Jacobs - Pr...